XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:        
Research and development $ 6,802 $ 5,659 $ 18,087 $ 15,870
General and administrative 1,780 1,369 7,719 3,495
Total operating expenses 8,582 7,028 25,806 19,365
Loss from operations (8,582) (7,028) (25,806) (19,365)
Interest income 19 (2) 118 2
Interest expense - related party   (380) (121) (722)
Australian research and development incentives 961   1,852  
Foreign currency gains 787 133 823 184
Net loss (6,815) $ (7,277) (23,134) $ (19,901)
Accretion of preferred stock to redemption value     (244)  
Net loss attributable to common stockholders $ (6,815)   $ (23,378)  
Net loss per share - basic and diluted (in dollars per share) $ (0.73)   $ (2.72)  
Weighted average common shares outstanding - basic and diluted (in shares) 9,395,920   8,584,558